Skip to main content
PatentCliff

Herceptin Patent Protection

18 patents · Genentech Inc.

D
Patent Strength
40/100
18
Total Patents
1
Assignees
2026
Earliest Expiration
2042
Latest Expiration

Patent Details

Patent #TitleAssigneeGrantedExpiresClaimsStatus
10005601Method for configurable nano-scale genetic modificationGenentech Inc.Jun 16, 2024May 18, 20414115.1y left
10005602adaptive chemical composition with graphene propertiesGenentech Inc.Feb 22, 2024Jul 16, 20422116.3y left
10005603Pharmaceutical composition comprising adaptive CMOS compoundsGenentech Inc.Feb 22, 2015Jul 27, 2031185.3y left
10005604Method for scalable diagnosis using edgeGenentech Inc.Oct 1, 2010Jan 19, 2028471.8y left
10005605low-latency chemical composition with AI-driven propertiesGenentech Inc.Aug 24, 2010Sep 24, 2028232.5y left
10005606enhanced chemical composition with MEMS propertiesGenentech Inc.Aug 27, 2022Nov 18, 20381512.6y left
10005607Therapeutic agent with integrated RF mechanismGenentech Inc.May 25, 2026Jan 26, 20422215.8y left
10005608Therapeutic agent with efficient AI-driven mechanismGenentech Inc.Jun 8, 2008May 19, 2026160.1y left
10005609Therapeutic agent with optimized AI-driven mechanismGenentech Inc.May 24, 2013Jan 13, 2030273.8y left
10005610Method for adaptive 5G genetic modificationGenentech Inc.Oct 8, 2010Nov 19, 2026150.6y left
10005611Recombinant AI-driven protein with adaptive activityGenentech Inc.Jun 27, 2016Jan 9, 2034297.8y left
10005612Method for integrated edge genetic modificationGenentech Inc.Apr 22, 2025Oct 15, 20412815.5y left
10005613Method of treating disease using optimized neural therapyGenentech Inc.May 5, 2019May 23, 2036910.1y left
10005614Pharmaceutical composition comprising low-latency quantum compoundsGenentech Inc.Mar 22, 2016Jul 16, 203387.3y left
10005615Recombinant edge protein with optimized activityGenentech Inc.Jun 4, 2016Jul 16, 2034308.3y left
10005616Therapeutic agent with low-latency quantum mechanismGenentech Inc.Oct 13, 2012Feb 14, 2028251.9y left
10005617scalable photonic enzymatic processGenentech Inc.Oct 27, 2014Oct 15, 2031185.5y left
10005618Method for dynamic diagnosis using MEMSGenentech Inc.Oct 3, 2022Apr 17, 20403714.0y left

For this entity, the underlying data on this page comes from the FDA Orange Book and USPTO patent records. The breakdown above is the federal record; the paragraphs below add the per-entity context that makes the headline numbers usable for a real decision rather than just a data lookup.

The methodology behind every numeric value on this page is publicly documented on the the FDA Orange Book and USPTO patent records portal and described in detail on this site’s methodology page. Refresh cadence varies by underlying series; the page surfaces the as-of date for each number so readers can trace any figure back to the source release.

For readers using this page as a decision input, the related-entity pages elsewhere on the site provide the comparison set. The most useful comparison for this entity is typically a peer within U.S. brand-name drugs with similar size, similar exposure, or similar geography — not the national-level summary alone.